REQUEST A DEMO
Total
USD $0.00
Search more companies

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (China)

Main Activities: Analytical Laboratory Instrument Manufacturing
Full name: Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Wuhan Easy Diagnosis Biomedicine Co., Ltd. is engaged in the independent research, development, production and sales of POCT rapid diagnostic reagents and rapid detection instruments. The main products of the company include POCT rapid diagnostic reagents and rapid detection instruments, of which the rapid diagnostic reagents are divided into six categories: infectious diseases series, cardiovascular and cerebrovascular disease series, kidney disease series, diabetes series, gynecology and obstetrics and health care series, and physical examination series. The company was established in 2008 and is headquartered in Wuhan City, Hubei Province.

Headquarters
Room 1, 1st Floor, Building 22, Phase 1.2, Wuhan Optics Valley International Biomedical Enterprise Accelerator, No. 388, Gaoxin 2nd Road, East Lake High-tech Development Zone, Wuhan City, Hubei Province
Wuhan; Hubei; Postal Code: 430075

Contact Details: Purchase the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. report to view the information.

Website: http://www.mdeasydiagnosis.com

Basic Information
Total Employees:
Purchase the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. report to view the information.
Incorporation Date:
January 28, 2008
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
27.06%
Purchase this report to view the information.
15.45%
Purchase this report to view the information.
2.21%
Purchase this report to view the information.
1.3%
Purchase this report to view the information.
0.85%
Subsidiaries
Changsha Mingde Biotechnology Co., Ltd.
100%
Hubei Mingde Medical Technology Co., Ltd.
100%
Hubei Minghui Health Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Wuhan Easy Diagnosis Biomedicine Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-63.95%
Total operating revenue
-53.52%
Operating profit (EBIT)
-62.49%
Net Profit (Loss) for the Period
-65.86%
Total assets
-11.41%
Total equity
-4.38%
Operating Profit Margin (ROS)
1.43%
Net Profit Margin
-1.54%
Return on Equity (ROE)
-1.84%
Debt to Equity Ratio
-2.12%
Quick Ratio
-0.42%
Cash Ratio
-1.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?